Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (37)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Chesebro, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chesebro, B.
Related Collections
Right arrow Immunology
Right arrow Infectious Diseases
Right arrow Neurology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Medical Bulletin 66:1-20 (2003)
© 2003 The British Council

Introduction to the transmissible spongiform encephalopathies or prion diseases

Bruce Chesebro

Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institutes of Allergy and Infectious Diseases, Hamilton, Montana, USA

Sheep scrapie has been known for at least 200 years and was described as a transmissible disease over 100 years ago. Since then, three groups of transmissible spongiform encephalopathies or TSE diseases have been identified in humans including familial, infectious and sporadic types. The discovery of the prion protein (PrP) in the 1980s greatly accelerated knowledge of the biology and pathogenesis of TSE diseases as this protein was found to play a critical role in disease susceptibility and the TSE species-barrier and may also be a component of the infectious agent itself. Nevertheless, the nature of the TSE agents remains an enigma. Proof of the protein-only hypothesis may require generation of biologically active transmissible agent in a cell-free environment where a virus cannot replicate. Conversely, proof of a viral aetiology will require identification and isolation of a candidate virus. Further understanding of the structure of the disease-associated protease-resistant PrP should help elucidate the mechanism of PrP conversion from the normal to the abnormal form. Such information should open up new approaches to both diagnosis and therapy.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Dent. Res.Home page
J.T. Walker, J. Dickinson, J.M. Sutton, P.D. Marsh, and N.D.H. Raven
Implications for Creutzfeldt-Jakob Disease (CJD) in Dentistry: a Review of Current Knowledge
J. Dent. Res., June 1, 2008; 87(6): 511 - 519.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
P. Brown
Transmissible spongiform encephalopathy in the 21st century: Neuroscience for the clinical neurologist
Neurology, February 26, 2008; 70(9): 713 - 722.
[Full Text] [PDF]


Home page
J. Virol.Home page
K. Meade-White, B. Race, M. Trifilo, A. Bossers, C. Favara, R. Lacasse, M. Miller, E. Williams, M. Oldstone, R. Race, et al.
Resistance to Chronic Wasting Disease in Transgenic Mice Expressing a Naturally Occurring Allelic Variant of Deer Prion Protein
J. Virol., May 1, 2007; 81(9): 4533 - 4539.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Atarashi, V. L. Sim, N. Nishida, B. Caughey, and S. Katamine
Prion strain-dependent differences in conversion of mutant prion proteins in cell culture.
J. Virol., August 1, 2006; 80(16): 7854 - 7862.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
A. S. Rambold, M. Miesbauer, D. Rapaport, T. Bartke, M. Baier, K. F. Winklhofer, and J. Tatzelt
Association of Bcl-2 with Misfolded Prion Protein Is Linked to the Toxic Potential of Cytosolic PrP
Mol. Biol. Cell, August 1, 2006; 17(8): 3356 - 3368.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
R. A. Moore, C. Herzog, J. Errett, D. A. Kocisko, K. M. Arnold, S. F. Hayes, and S. A. Priola
Octapeptide repeat insertions increase the rate of protease-resistant prion protein formation
Protein Sci., March 1, 2006; 15(3): 609 - 619.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
I. Alexeeva, E. J. Elliott, S. Rollins, G. E. Gasparich, J. Lazar, and R. G. Rohwer
Absence of Spiroplasma or Other Bacterial 16S rRNA Genes in Brain Tissue of Hamsters with Scrapie
J. Clin. Microbiol., January 1, 2006; 44(1): 91 - 97.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Nakayashiki, C. P. Kurtzman, H. K. Edskes, and R. B. Wickner
Yeast prions [URE3] and [PSI+] are diseases
PNAS, July 26, 2005; 102(30): 10575 - 10580.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
B. Chesebro, M. Trifilo, R. Race, K. Meade-White, C. Teng, R. LaCasse, L. Raymond, C. Favara, G. Baron, S. Priola, et al.
Anchorless Prion Protein Results in Infectious Amyloid Disease Without Clinical Scrapie
Science, June 3, 2005; 308(5727): 1435 - 1439.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
C. Castro-Fernandez, G. Maya-Nunez, and P. M. Conn
Beyond the Signal Sequence: Protein Routing in Health and Disease
Endocr. Rev., June 1, 2005; 26(4): 479 - 503.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
N. Gilks, N. Kedersha, M. Ayodele, L. Shen, G. Stoecklin, L. M. Dember, and P. Anderson
Stress Granule Assembly Is Mediated by Prion-like Aggregation of TIA-1
Mol. Biol. Cell, December 1, 2004; 15(12): 5383 - 5398.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
R. B. Rock, G. Gekker, S. Hu, W. S. Sheng, M. Cheeran, J. R. Lokensgard, and P. K. Peterson
Role of Microglia in Central Nervous System Infections
Clin. Microbiol. Rev., October 1, 2004; 17(4): 942 - 964.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
R. B. Wickner, H. K. Edskes, B. T. Roberts, U. Baxa, M. M. Pierce, E. D. Ross, and A. Brachmann
Prions: proteins as genes and infectious entities
Genes & Dev., March 1, 2004; 18(5): 470 - 485.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.